{"id":"W4411289812","doi":"10.1158/1557-3265.sabcs24-p3-12-05","title":"Abstract P3-12-05: Real-world use of sacituzumab govitecan (SG) in the management of metastatic triple-negative breast cancer (mTNBC) through a Canadian Patient Support Program (PSP)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Medicine; Metastatic breast cancer; Cancer; Oncology; Breast cancer; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005173511,0.0001848286,0.0002100236,0.0002435824,0.001057743,0.0006550708,0.0004975584,0.000299525,0.002309435],"category_scores_gemma":[0.0009017723,0.0001377936,0.0003406433,0.0006956516,0.0004073739,0.0001988844,0.0003034767,0.0006063961,0.0002958646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008553643,"about_ca_system_score_gemma":0.01042113,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5147332,"about_ca_topic_score_gemma":0.7212553,"domain_scores_codex":[0.9995781,0.00005974379,0.00001667726,0.00007847512,0.0001545471,0.0001124924],"domain_scores_gemma":[0.9991406,0.00005566944,0.0002987417,0.00003975549,0.0001358025,0.0003294707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01324045,0.002772506,0.9039903,0.0002425681,0.0004089304,0.0004537342,0.0006058167,0.0008412525,0.003669066,0.0002091806,0.009717429,0.06384876],"study_design_scores_gemma":[0.001088973,0.003484682,0.9862326,0.00004683847,0.0001786879,0.00031106,0.0002965713,0.0006151054,0.0006830015,0.00004216735,0.007001861,0.00001834182],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993596,0.0002412517,0.00009105096,0.0002554751,0.00000819346,0.0002334764,0.003729593,0.00001345804,0.001831591],"genre_scores_gemma":[0.9951527,0.0002071796,0.0003081553,0.0002533456,0.00001831632,0.0001121808,0.002814679,0.000005535961,0.001127895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4852668,"threshold_uncertainty_score":0.9762493,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2405325944563751,"score_gpt":0.5369587132434502,"score_spread":0.2964261187870751,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}